Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 348
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if Dymista nasal spray is better and safer than placebo in treating children ages 4 to \<12 years old who have seasonal allergic rhinitis.

Detailed description:

Arms:
arm 1: (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137mcg/50mcg: Mode of Administration: Topical/intranasal spray

Dose: 548 mcg azelastine hydrochloride / 200 mcg fluticasone propionate, total daily dose Regimen: 1 spray per nostril twice daily arm 2: Dose: vehicle only Regimen: 1 spray per nostril twice daily

Interventions: intervention 1: azelastine hydrochloride and fluticasone propionate intervention 2: Dymista vehicle
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: